{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:14:47Z","timestamp":1780514087389,"version":"3.54.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100010892","name":"Department of Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100010892","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004728","name":"VIT University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004728","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jmgm.2017.06.007","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T05:00:45Z","timestamp":1496898045000},"page":"390-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Drug Resistance Mechanism of L10F, L10F\/N88S and L90M mutations in CRF01_AE HIV-1 protease: Molecular dynamics simulations and binding free energy calculations"],"prefix":"10.1016","volume":"75","author":[{"given":"C.S.","family":"Vasavi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramasamy","family":"Tamizhselvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Punnagai","family":"Munusami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2017.06.007_bib0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/CMR.14.2.327-335.2001","article-title":"Global impact of human immunodeficiency virus and AIDS","volume":"14","author":"Gayle","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0010","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.apjtb.2016.03.008","article-title":"Will there be a cure for HIV\/AIDS? Making the dream a reality","volume":"6","author":"Troncoso","year":"2016","journal-title":"Asia Pac. J. Trop. Biomed."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0015","doi-asserted-by":"crossref","first-page":"a006841","DOI":"10.1101\/cshperspect.a006841","article-title":"Origins of HIV and the AIDS pandemic","volume":"1","author":"Sharp","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0020","doi-asserted-by":"crossref","first-page":"14650","DOI":"10.1021\/ja907088a","article-title":"Subtype polymorphisms among HIV-1 protease variants confer altered flap conformations and flexibility","volume":"131","author":"Kear","year":"2009","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0025","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.2165\/00003495-200565130-00002","article-title":"Emerging drug targets for antiretroviral therapy","volume":"65","author":"Reeves","year":"2005","journal-title":"Drugs"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0030","doi-asserted-by":"crossref","first-page":"a006924","DOI":"10.1101\/cshperspect.a006924","article-title":"HIV-1 assembly, budding, and maturation","volume":"2","author":"Sundquist","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1039\/b208248a","article-title":"HIV-1 protease: mechanism and drug discovery","volume":"1","author":"Brik","year":"2003","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0040","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/2045-3701-2-32","article-title":"Effects of HIV-1 protease on cellular functions and their potential applications in antiretroviral therapy","volume":"2","author":"Yang","year":"2012","journal-title":"Cell Biosci."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0045","doi-asserted-by":"crossref","first-page":"49110","DOI":"10.1074\/jbc.M108136200","article-title":"Folded monomer of HIV-1 protease","volume":"276","author":"Ishima","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0050","first-page":"332","article-title":"Protease inhibitors for patients with HIV-1 infection","volume":"36","author":"Hughes","year":"2011","journal-title":"P T"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0055","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.3390\/v2112509","article-title":"Molecular basis for drug resistance in HIV-1 protease","volume":"2","author":"Ali","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0060","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.virol.2015.03.021","article-title":"Retroviral proteases and their roles in virion maturation","volume":"479\u2013480","author":"Konvalinka","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0020112","article-title":"Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration","volume":"2","author":"Kantor","year":"2005","journal-title":"PLoS Med."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0070","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1056\/NEJMra0706737","article-title":"The challenge of HIV-1 subtype diversity","volume":"358","author":"Taylor","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0075","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/QAD.0b013e3283350eef","article-title":"Protease polymorphisms in HIV-1 subtype CRF01_AE represent selection by antiretroviral therapy and host immune pressure","volume":"24","author":"Manosuthi","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0080","doi-asserted-by":"crossref","first-page":"17203","DOI":"10.1074\/jbc.M114.571836","article-title":"The role of select subtype polymorphisms on HIV-1 protease conformational sampling and dynamics","volume":"289","author":"Huang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0085","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1086\/386291","article-title":"Identification of I50L as the signature atazanavir (ATV)-resistance mutation in treatment-naive HIV-1-infected patients receiving ATV-containing regimens","volume":"189","author":"Colonno","year":"2004","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0090","doi-asserted-by":"crossref","first-page":"11956","DOI":"10.1021\/ja504096m","article-title":"Drug resistance conferred by mutations outside the active site through alterations in the dynamic and structural ensemble of HIV-1 protease","volume":"136","author":"Ragland","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0095","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3390\/v1031110","article-title":"HIV-1 protease: structural perspectives on drug resistance","volume":"1","author":"Weber","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0100","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/v2020503","article-title":"HIV genetic diversity and drug resistance","volume":"2","author":"Santos","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0105","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/jp046860+","article-title":"Resistant mechanism against nelfinavir of human immunodeficiency virus type 1 proteases","volume":"109","author":"Ode","year":"2005","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0110","doi-asserted-by":"crossref","first-page":"7887","DOI":"10.1021\/ja060682b","article-title":"Computational simulations of HIV-1 proteases multi-drug resistance due to nonactive site mutation L90\u2009M","volume":"128","author":"Ode","year":"2006","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0115","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00126334-200307010-00007","article-title":"Patterns of point mutations associated with antiretroviral drug treatment failure in CRF01_AE (subtype E) infection differ from subtype B infection","volume":"33","author":"Ariyoshi","year":"2003","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0120","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1089\/aid.2004.20.1368","article-title":"Sequence variability of the HIV type 1 protease gene in thai patients experienced with antiretroviral therapy","volume":"20","author":"Nukoolkarn","year":"2004","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0125","doi-asserted-by":"crossref","first-page":"9995","DOI":"10.1128\/JVI.00505-10","article-title":"The effect of clade-specific sequence polymorphisms on HIV-1 protease activity and inhibitor resistance pathways","volume":"84","author":"Bandaranayake","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0130","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1021\/jm061158i","article-title":"Mechanism of drug resistance due to N88S in CRF01_AE HIV-1 protease, analyzed by molecular dynamics simulations","volume":"50","author":"Ode","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0135","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1515\/hsz-2014-0162","article-title":"Non-B HIV-1 subtypes in sub-Saharan Africa: impact of subtype on protease inhibitor efficacy","volume":"395","author":"Naicker","year":"2014","journal-title":"Biol. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0140","doi-asserted-by":"crossref","first-page":"17355","DOI":"10.1073\/pnas.0607274103","article-title":"Genotypic predictors of human immunodeficiency virus type 1 drug resistance","volume":"103","author":"Rhee","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0145","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jcv.2005.10.012","article-title":"Clinical utility of genotyping resistance test on determining the mutation patterns in HIV-1 CRF01_AE and subtype B patients receiving antiretroviral therapy in Hong Kong","volume":"35","author":"Yam","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0150","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jmgm.2010.05.007","article-title":"Understanding the HIV-1 protease nelfinavir resistance mutation D30N in subtypes B and C through molecular dynamics simulations","volume":"29","author":"Soares","year":"2010","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0155","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.molstruc.2010.11.027","article-title":"Resistant mechanism against nelfinavir of subtype C human immunodeficiency virus type 1 proteases","volume":"986","author":"Liu","year":"2011","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0160","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jmb.2007.09.083","article-title":"Molecular analysis of the HIV-1 resistance development: enzymatic activities, crystal structures, and thermodynamics of nelfinavir-resistant HIV protease mutants","volume":"374","author":"Ko\u017e\u00ed\u0161ek","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0165","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2174\/138920306777452312","article-title":"Advances in homology protein structure modeling","volume":"7","author":"Xiang","year":"2006","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0170","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-60761-842-3_6","article-title":"Template-based protein structure modeling","volume":"673","author":"Fiser","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0175","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/cbdd.12690","article-title":"Binding free energy calculations of nine FDA-approved protease inhibitors against HIV-1 subtype C I36T\u2191T containing 100 amino acids per monomer","volume":"87","author":"Lockhat","year":"2016","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0180","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/cbdd.12063","article-title":"Comparison of the molecular dynamics and calculated binding free energies for nine FDA-approved HIV-1 PR drugs against subtype B and C-SA HIV PR","volume":"81","author":"Ahmed","year":"2013","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0185","doi-asserted-by":"crossref","first-page":"e87520","DOI":"10.1371\/journal.pone.0087520","article-title":"New insights into the In silico prediction of HIV protease resistance to nelfinavir","volume":"9","author":"Antunes","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0190","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1021\/jm9704098","article-title":"Viracept (Nelfinavir mesylate, AG1343):a potent, orally bioavailable inhibitor of HIV-1 protease","volume":"40","author":"Kaldor","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0195","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.1093\/nar\/gku316","article-title":"Deciphering key features in protein structures with the new ENDscript server","volume":"42","author":"Robert","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0200","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","article-title":"Comparative protein modelling by satisfaction of spatial restraints","volume":"234","author":"Sali","year":"1993","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0205","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/prot.10286","article-title":"Structure validation by Calpha geometry: phi, psi and Cbeta deviation","volume":"50","author":"Lovell","year":"2003","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0210","unstructured":"Accelrys Discovery Studio (2012) San Diego: Accelrys Software Inc. Accelrys Discovery Studio modeling environment, release 3.5."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0215","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0220","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1021\/ct200909j","article-title":"Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized born","volume":"8","author":"G\u00f6tz","year":"2012","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0225","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0230","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/jcc.10349","article-title":"A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations","volume":"24","author":"Duan","year":"2003","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0235","series-title":"Gaussian 09, Revision E.01","author":"Frisch","year":"2009"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0240","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1002\/jcc.10128","article-title":"Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation","volume":"23","author":"Jakalian","year":"2002","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0245","doi-asserted-by":"crossref","first-page":"W511","DOI":"10.1093\/nar\/gkr288","article-title":"R.E.D. Server: a web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments","volume":"39","author":"Vanquelef","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0250","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical-integration of cartesian equations of motion of a system with constraints \u2013 molecular-dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0255","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1080\/00268976.2013.857050","article-title":"Protonation state and free energy calculation of HIV-1 protease\u2013inhibitor complex based on electrostatic polarisation effect","volume":"112","author":"Yang","year":"2014","journal-title":"Mol. Phys."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0260","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/jcc.20821","article-title":"Accurate prediction of protonation state as a prerequisite for reliable MM-PB(GB)SA binding free energy calculations of HIV-1 protease inhibitors","volume":"29","author":"Wittayanarakul","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0265","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jcc.21372","article-title":"Fast and accurate predictions of binding free energies using MM-PBSA and MM-GBSA","volume":"31","author":"Rastelli","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0270","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/prot.20033","article-title":"Exploring protein native states and large-scale conformational changes with a modified generalized born model","volume":"55","author":"Onufriev","year":"2004","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0275","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK: a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. Appl. Cryst. J. Appl. Crystallogr."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0280","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1021\/ci300385h","article-title":"Molecular dynamics investigation on a series of HIV protease inhibitors: assessing the performance of MM-PBSA and MM-GBSA approaches","volume":"52","author":"Srivastava","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0285","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jmr.2377","article-title":"Switches of hydrogen bonds during ligand-protein association processes determine binding kinetics","volume":"27","author":"Huang","year":"2014","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0290","doi-asserted-by":"crossref","first-page":"e1501240","DOI":"10.1126\/sciadv.1501240","article-title":"Regulation of protein-ligand binding affinity by hydrogen bond pairing","volume":"2","author":"Chen","year":"2016","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jmgm.2017.06.007_bib0295","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/prot.22625","article-title":"Highly conserved glycine 86 and arginine 87 residues contribute differently to the structure and activity of the mature HIV-1 protease","volume":"78","author":"Ishima","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0300","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/prot.1057","article-title":"Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease\/substrate analogue complexes","volume":"43","author":"Mahalingam","year":"2001","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0305","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1021\/bi00057a007","article-title":"Molecular dynamics simulation of HIV-1 protease in a crystalline environment and in solution","volume":"32","author":"York","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2017.06.007_bib0310","doi-asserted-by":"crossref","first-page":"10517","DOI":"10.1038\/srep10517","article-title":"Effects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir","volume":"5","author":"Yu","year":"2015","journal-title":"Sci. Rep."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326317301018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326317301018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:56:20Z","timestamp":1761080180000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326317301018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":62,"alternative-id":["S1093326317301018"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2017.06.007","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug Resistance Mechanism of L10F, L10F\/N88S and L90M mutations in CRF01_AE HIV-1 protease: Molecular dynamics simulations and binding free energy calculations","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2017.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}